Urologix software gets US FDA approval:
This article was originally published in Clinica
Executive Summary
Urologix has received US FDA approval for its Cruise II enhancement for the Targis Cruise Control urological microwave catheter software. The new version incorporates a unique dual sensor feedback system providing automated safety controls and improved ease of use. The system achieves and sustains therapeutic temperatures within the prostate for an optimal treatment by utilising urethral and rectal temperatures, said the Minneapolis, Minnesota-based company.